Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Chromatics Color Sciences International. Inc; CCSI -- Ignore unavailable to you. Want to Upgrade?

To: David S. who wrote (950)	2/4/1998 12:05:00 PM
From: Ron Harvey	Respond to of 5736

Thanks for the info from Proxy Monitor. I had already read the proxy on my own and voted for the split and against the other two items for basically the same reasons as cited by PM. It's interesting to see my concerns corroborated. However, insiders own so much of the stock that it's a sure thing that all three items will pass. Unfortunately, it's not uncommon that public companies are run for the benefit of the officers and execs. However, if I spent years working on a startup and saw that it was finally beginning to bear fruit, I'm sure I'd do the same thing. I'd feel an obligation to the initial venture capitalists, but for those who bought in the secondary markets (like me and everyone here) I wouldn't feel indebted, although I'd certainly sing the right songs about deeply caring for stock holders and would have no trouble putting on an appropriate public face. Meanwhile, there's still a lot more upside potential in the stock at the current price than downside risk. Finally, I don't think the CEO's personal life is anyone's business here.